These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 3425313)
21. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
22. Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements. Chuchalin A; Amelina E; Bianco F Pulm Pharmacol Ther; 2009 Dec; 22(6):526-32. PubMed ID: 19616111 [TBL] [Abstract][Full Text] [Related]
23. Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis. Somayaji R; Parkins MD Ther Deliv; 2015 Feb; 6(2):121-37. PubMed ID: 25690082 [TBL] [Abstract][Full Text] [Related]
24. [Use of inhaled tobramycin in patients with cystic fibrosis]. Chermenskiĭ AG; Gembitskaia TE Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251 [TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Blumer JL; Saiman L; Konstan MW; Melnick D Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892 [TBL] [Abstract][Full Text] [Related]
26. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Johansen HK; Høiby N Thorax; 1992 Feb; 47(2):109-11. PubMed ID: 1549817 [TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
35. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. Ciofu O; Giwercman B; Pedersen SS; Høiby N APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270 [TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082 [TBL] [Abstract][Full Text] [Related]
37. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review. Ratjen F; Brockhaus F; Angyalosi G J Cyst Fibros; 2009 Dec; 8(6):361-9. PubMed ID: 19747887 [TBL] [Abstract][Full Text] [Related]
38. Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis. Hoogkamp-Korstanje JA; van der Laag J J Antimicrob Chemother; 1983 Aug; 12(2):175-83. PubMed ID: 6619055 [TBL] [Abstract][Full Text] [Related]
39. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. Pedersen SS; Koch C; Høiby N; Rosendal K J Antimicrob Chemother; 1986 Apr; 17(4):505-16. PubMed ID: 3086274 [TBL] [Abstract][Full Text] [Related]
40. Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. Stenvang Pedersen S; Pressler T; Pedersen M; Høiby N; Friis-Møller A; Koch C Scand J Infect Dis; 1986; 18(2):133-7. PubMed ID: 3518048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]